邱贤秀,女,博士,副教授,硕士生导师。香港理工大学“化学生物学与药物研发国家重点实验室”博士(2013-2017),香港理工大学博士后(2018-2019),美国西北大学Feinberg医学院访问学者。现任东莞市医学活性分子开发与转化重点实验室副主任,广东省生物医学工程学会健康工程分会委员。
近年来主要从事细胞自噬相关蛋白的结构功能与分子机制研究、以及基于蛋白结构的活性药物分子的研发。以第一作者或通讯作者在Proc Natl Acad Sci U S A(PNAS)、Autophagy、J Med Chem等杂志上发表 SCI 论文多篇,参与获授权美国专利1项,申请中国发明专利3项。主持国家自然科学基金、广东省自然科学基金、粤莞联合基金、深圳市科技创新委员会研究项目、广东省中医药局科研项目、湛江市科技发展专项等多个科研项目。
Xianxiu Qiu#, Li Na, Qifan Yang, Shuai Wu, Xiaohua Li, Xuehua Pan, Soh Yamamoto, Xiaozhe Zhang, Jincheng Zeng, Jiahao Liao, Congcong He, Renxiao Wang*, Yanxiang Zhao*. The potent BECN2-ATG14 coiled coil interaction is selectively critical for endolysosomal degradation of GASP1-associated GPCRs.Autophagy,2023 Jul 13;1-15. (中科院一区TOP)
Shuai Wu#, Yunjiao He#,XianxiuQiu#,Wenchao Yang, Wenchao Liu, Xiaohua Li, Yan Li, Han-Ming Shen, Renxiao Wang, Zhenyu Yue, Yanxiang Zhao*.Targeting the potent Beclin 1-UVRAG coiled-coil interaction with designed peptides enhances autophagy andendolysosomal trafficking,Proc Natl Acad Sci U S A.2018,115(25): E5669-E5678.(中科院一区TOP)
Qifan Yang#;XianxiuQiu#; Xiaozhe Zhang; Yingting Yu; Na Li; Xing Wei; Guoqin Feng; Yan Li; Yanxiang Zhao*; Renxiao Wang*. Optimization of Beclin 1-Targeting Stapled Peptides by Staple Scanning Leads to Enhanced Antiproliferative Potency in Cancer Cells,Journal of Medicinal Chemistry, 2021, 64(18): 13475-13486.(中科院一区TOP)
Bin Wang#, Yanfang Liang#, Xingxing Chai#, Shasha Chen, Ziyu Ye, Ronggang Li, Xiaoping Li , Gang Kong, Yanyun Li, Xueying Zhang, Zhengping Che, Yongke You, Shicai Ye, Lili Li, Bihua Lin, Juan Huang, Mingyuan Huang, Xin Zhang,Xianxiu Qiu*, Jincheng Zeng *.Ectodysplasin A receptor (EDAR) promotes colorectal cancer cell proliferation via regulation of the Wnt/β-catenin signaling pathway,Experimental Cell Research. 2020, 395 (1).
Lian J#, Liang Y#, Zhang H#, Lan M, Ye Z, Lin B, Qiu X*, Zeng J*. The role of polyamine metabolism in remodeling immune responses and blocking therapy within the tumor immune microenvironment. Frontiers in Immunology,2022 2;13:912279.
Kang-Zhen Chen; Shu-Xian Liu; Yan-Wei Li; Tao He; Jie Zhao; Tao Wang;Xian-Xiu Qiu*; Hong- Fu Wu*; Vimentin as a potential target for diverse nervous system diseases,Neural Regeneration Research, 2022, 18(5): 969-973
代表性科研项目
1,国自然青年科学基金项目,32000864,2021.01至2023.12,24万元,主持;
2,广东省自然科学基金(面上项目),2021A1515012054,2021.01至2023.12,10万元,主持;
3,广东省基础与应用基础项目(粤莞联合基金),2019A1515110357,2020.01至2021.12,10万元,主持;
4,深圳市科技创新委员会基础研究项目,JCYJ20180306173853283,2019.04至2021.09,40万元,主持;
5,湛江市科技发展专项资金竞争性分配项目,2020A01028,2020.09至2022.09,5万元,主持;
6,437必赢会员中心学科建设-“临床+基础专项”,2024.01-2026.12,90万元,主持。